Enjoy complimentary customisation on priority with our Enterprise License!
The point of care glucose testing market size is forecast to increase by USD 874.6 million at a CAGR of 4.91% between 2023 and 2028. Diabetes is a chronic condition characterized by elevated blood sugar levels, affecting an estimated 463 million people worldwide. With the increasing number of diabetes cases and rising awareness about the disease, there is a growing demand for effective solutions in its diagnosis and management. Furthermore, the geriatric population, which is more susceptible to diabetes due to age-related factors, is expanding rapidly. This demographic shift creates an unmet medical need for innovative diabetes care solutions that cater to the unique requirements of older adults. In response, companies like Novo Nordisk are focusing on developing advanced technologies and therapies to improve diabetes care, ensuring better patient outcomes and quality of life. The market report provides market size, historical data, and future projections, all presented in terms of value in USD million for each of the mentioned segments.
For More Highlights About this Report, Request Free Sample
Point-of-care (PoC) glucose testing is a critical aspect of diabetes management, allowing healthcare professionals and patients to monitor blood glucose levels in real-time. This testing is essential for immediate results, which can significantly impact patient outcomes and treatment plans, including medication dosages. PoC glucose testing utilizes biosensor technologies and digital health platforms to provide accurate readings. Electronic health records and remote patient monitoring enable easy access to patient data, enhancing the effectiveness of PoC glucose testing. The PoC glucose testing market is driven by the increasing prevalence of chronic diseases, particularly Type 2 diabetes. The market is growing due to the convenience of handheld devices, such as the Accu-Chek Inform II, and the availability of affordable glucose testing strips. The home care setting is a significant market for PoC glucose testing, enabling patients to manage their blood sugar levels independently and reduce healthcare costs. Overall, PoC glucose testing plays a vital role in diabetes management, improving patient outcomes and reducing healthcare expenses.
Increase in the number of diabetes cases and rising awareness about diabetes is notably driving market growth. Point-of-care (PoC) glucose testing has gained significant importance in managing diabetes and pre-diabetes. With an estimated 34.2 million Americans living with diabetes in 2020, according to the Centers for Disease Control and Prevention (CDC), the demand for diabetes testing products, including handheld PoC glucose testing devices, is on the rise.
THus, such devices offer convenience and quick results, enabling patients to monitor their blood sugar levels regularly and make necessary lifestyle adjustments or medication adjustments as needed. Leading companies like LifeScan contribute to this market with innovative solutions. The increasing prevalence of diabetes and pre-diabetes, coupled with the need for convenient and accurate glucose testing, presents substantial growth opportunities for the PoC glucose diagnostics market. Thus, such factors are driving the growth of the market during the forecast period.
Focus on introducing low-cost test strips is the key trend in the market. Point-of-care (PoC) glucose testing has gained significant traction due to the convenience it offers in managing diabetes. Vendors in this market are prioritizing the development of cost-effective handheld devices for PoC glucose diagnostics to cater to the increasing demand. Traditional blood glucose test strips are made of plastic or paper, which require expensive devices to embed electrodes for conducting electrical currents to measure glucose levels. In contrast, silk strips only necessitate a spray with enzymes, as the coated threads of silk can conduct electrochemical signals, thereby reducing the need for costly mechanical devices.
Notably, silk strips are more economical compared to their paper and plastic counterparts. For instance, LifeScan, a leading player in the PoC glucose diagnostics market, offers silk-based test strips. This trend is expected to revolutionize the PoC glucose testing market by offering affordable yet technologically advanced solutions. Thus, such trends will shape the growth of the market during the forecast period.
Lower diagnosis and treatment rate is the major challenge that affects the growth of the market. Point-of-care (PoC) glucose testing has gained significant attention due to its convenience and ability to provide quick results for individuals with diabetes. However, the adoption of PoC glucose testing, particularly in emerging economies such as India, China, Nepal, and others, is hindered by the substantial number of undiagnosed diabetic patients. According to International Diabetes Federation data from 2021, over 55% of diabetic patients in the Asia-Pacific region remain undiagnosed, with India, China, and Indonesia having the highest numbers.
Moreover, limited access to advanced healthcare infrastructure further impedes market growth. Handheld devices, such as those manufactured by LifeScan, are increasingly being used to address this challenge by providing affordable and portable PoC glucose diagnostic solutions. These devices offer accuracy, ease of use, and quick results, making them a valuable tool in managing diabetes in resource-limited settings. Hence, the above factors will impede the growth of the market during the forecast period
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market forecast report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The strips segment is estimated to witness significant growth during the forecast period. Point-of-care (POC) glucose testing plays a significant role in managing diabetes by enabling healthcare professionals to obtain immediate results for blood glucose levels. This testing is crucial for optimizing patient outcomes, treatment plans, and medication dosages. POC glucose testing is gaining popularity in various settings, including diagnostic centers, research laboratories, home-care settings, and even telehealth services. Biosensor technologies and digital health platforms are driving the advancement of POC glucose testing, enabling accurate and precise readings. The geriatric population, who are more susceptible to chronic diseases like Type 2 diabetes, greatly benefit from POC glucose testing. POC testing eliminates the need for patients to visit diagnostic centers or hospitals for routine glucose checks, making it more accessible and convenient. POC glucose testing also facilitates remote patient monitoring, allowing healthcare professionals to keep track of patients' blood sugar levels from a distance.
Get a glance at the market share of various regions Download the PDF Sample
The strips segment accounted for USD 1.21 billion in 2018. Accuracy and precision are essential in POC glucose testing to ensure effective diabetes management. Calibration issues and quality control measures are crucial considerations to maintain the reliability of POC glucose testing. POC glucose testing is also integrated with electronic medical records, enabling seamless data sharing and analysis. Skilled staff is required to operate and maintain POC glucose testing equipment, ensuring the best possible patient care. Regulatory policies play a vital role in the adoption and implementation of POC glucose testing. POC glucose testing devices, such as the Accu-Chek Inform II, are subject to rigorous testing and certification to ensure their accuracy and safety. Patient data obtained from POC glucose testing is crucial for diabetes management, leading to improved patient outcomes and reduced mortality rates. POC glucose testing is revolutionizing diabetes management by providing immediate and accessible glucose level readings, enabling better treatment plans and medication dosages.
For more insights on the market share of various regions Download PDF Sample now!
Europe is estimated to contribute 34% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. Point-of-care (POC) testing for blood glucose levels plays a crucial role in diabetes management, providing healthcare professionals and patients with immediate results for effective treatment plans and medication dosages. POC testing is particularly valuable in various settings, including healthcare facilities, diagnostic centers, research laboratories, home-care settings, and telehealth services. Biosensor technologies and digital health platforms are driving advancements in POC glucose testing, enabling electronic health records and remote patient monitoring for chronic diseases like Type 2 diabetes.
Moreover, accuracy and precision are essential aspects of POC glucose testing, ensuring optimal patient outcomes and reducing healthcare costs. Calibration issues and quality control measures are critical considerations for maintaining the reliability and consistency of POC testing devices. The geriatric population, who are more susceptible to diabetes and its complications, significantly benefits from POC testing in various settings. Regulatory policies and electronic medical records play a pivotal role in the implementation and integration of POC glucose testing into healthcare systems. Skilled staff is necessary for proper use and interpretation of POC testing results, contributing to improved diabetes management and reduced mortality rates. POC testing devices, such as the Accu-Chek Inform II, provide patient data for continuous monitoring and analysis, allowing for more personalized and effective treatment plans.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million " for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
You may also interested in below market reports:
Point-of-care (POC) testing for blood glucose levels has become an essential tool in diabetes management. With the increasing prevalence of diabetes, both Type 1 and Type 2, the need for immediate and accurate glucose level results has grown significantly. Healthcare professionals rely on POC testing to make informed decisions regarding treatment plans, medication dosages, and patient outcomes. Biosensor technologies and digital health platforms have revolutionized POC testing, enabling real-time monitoring and electronic health records integration. POC testing is not limited to diagnostic centers and research laboratories. It is increasingly being used in home-care settings, telehealth services, and over-the-counter (OTC) testing.
Further, the accuracy and precision of POC testing are crucial, as calibration issues and quality control measures can impact patient outcomes and healthcare costs. The geriatric population, with a higher prevalence of chronic diseases and diabetes, benefits significantly from POC testing. Electronic medical records, skilled staff, and regulatory policies ensure the effective implementation of POC testing in diabetes management. Devices like Accu-Chek Inform II provide patient data for remote patient monitoring, improving mortality rate and overall healthcare management. POC testing plays a vital role in diabetes management, providing immediate results and enabling effective treatment plans.
Market Scope |
|
Report Coverage |
Details |
Page number |
134 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4.91% |
Market growth 2024-2028 |
USD 874.6 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
4.41 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
Europe at 34% |
Key countries |
US, UK, China, Canada, and India |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Abbott Laboratories, ACON Laboratories Inc., Bayer AG, Becton Dickinson and Co., Danaher Corp., EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., Johnson and Johnson Services Inc., LifeScan IP Holdings LLC, Nipro Corp., Nova Biomedical Corp., PHC Holdings Corp., Prodigy Diabetes Care LL, PTS Diagnostics, Sekisui Medical Co. Ltd., Siemens Healthineers AG, Trinity Biotech Plc, and Trivida Health Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.